{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:31:39Z","timestamp":1774441899129,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yan'an Science and Technology Plan Project","award":["2024-SFGG-109"],"award-info":[{"award-number":["2024-SFGG-109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02195-0","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:26:48Z","timestamp":1771327608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inferior metabolic control in isolated diabetic patients under the context of multimorbidity management: a comparative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jing","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuchu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2195_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41574-022-00793-1","volume":"19","author":"AYY Cheng","year":"2023","unstructured":"Cheng AYY, et al. Applying the WHO global targets for diabetes mellitus. Nat Rev Endocrinol. 2023;19:194\u2013200. https:\/\/doi.org\/10.1038\/s41574-022-00793-1.","journal-title":"Nat Rev Endocrinol"},{"key":"2195_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"AD Association","year":"2019","unstructured":"Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2019. Diabetes Care. 2019;42:S13\u201328. https:\/\/doi.org\/10.2337\/dc19-S002.","journal-title":"Diabetes Care"},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2025","unstructured":"Genitsaridi I, et al. 11th edition of the IDF diabetes atlas: global, regional, and National diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2025;14:149\u201356. https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3.","journal-title":"Lancet"},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"147916412110588","DOI":"10.1177\/14791641211058856","volume":"18","author":"S Thipsawat","year":"2021","unstructured":"Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021;18:14791641211058856. https:\/\/doi.org\/10.1177\/14791641211058856.","journal-title":"Diab Vasc Dis Res"},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"M-E Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 M-E, Tchernof A, Despr\u00e9s J-P. Obesity Phenotypes, Diabetes, and cardiovascular diseases. Circ Res. 2020;126:1477\u2013500. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316101.","journal-title":"Circ Res"},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","volume":"113","author":"P Balakumar","year":"2016","unstructured":"Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113:600\u20139. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.040.","journal-title":"Pharmacol Res"},{"key":"2195_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.pop.2020.08.004","volume":"47","author":"R Bonner","year":"2020","unstructured":"Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Prim Care. 2020;47:645\u201359. https:\/\/doi.org\/10.1016\/j.pop.2020.08.004.","journal-title":"Prim Care"},{"key":"2195_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18:525\u201339. https:\/\/doi.org\/10.1038\/s41574-022-00690-7.","journal-title":"Nat Rev Endocrinol"},{"key":"2195_CR10","doi-asserted-by":"publisher","first-page":"1626191","DOI":"10.3389\/fendo.2025.1626191","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Mapping the research landscape of the interactions between obesity and five major complications of diabetes: a bibliometric analysis using knowledge graph visualization. Front Endocrinol. 2025;16:1626191. https:\/\/doi.org\/10.3389\/fendo.2025.1626191.","journal-title":"Front Endocrinol"},{"key":"2195_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ajh\/hpab024","volume":"34","author":"Y Li","year":"2021","unstructured":"Li Y, Sun X, Wei J, Wu J, Wang Y. Time trends in comorbidity and management of hypertension and Self-reported diabetes: A 15-Year nationwide longitudinal study in China. Am J Hypertens. 2021;34:810\u201320. https:\/\/doi.org\/10.1093\/ajh\/hpab024.","journal-title":"Am J Hypertens"},{"key":"2195_CR12","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303375795250521041740","author":"Z Hashempour","year":"2025","unstructured":"Hashempour Z, Esmaeili F, Tabatabaei-Malazy O, Mosallanejad A, Panahi G. Worldwide prevalence of dyslipidemia in diabetes: an umbrella overview of the Meta-Analysis studies. Endocr Metab Immune Disord Drug Targets. 2025. https:\/\/doi.org\/10.2174\/0118715303375795250521041740.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2195_CR13","doi-asserted-by":"publisher","first-page":"1600333","DOI":"10.3389\/fendo.2025.1600333","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, et al. The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD 2021 data. Front Endocrinol. 2025;16:1600333. https:\/\/doi.org\/10.3389\/fendo.2025.1600333.","journal-title":"Front Endocrinol"},{"key":"2195_CR14","doi-asserted-by":"publisher","unstructured":"Porth A-K, et al. Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM\u2019s Diabesity Day Survey 2024. Eur J Intern Med. 2025;106583. https:\/\/doi.org\/10.1016\/j.ejim.2025.106583.","DOI":"10.1016\/j.ejim.2025.106583"},{"key":"2195_CR15","doi-asserted-by":"publisher","first-page":"1626225","DOI":"10.3389\/fendo.2025.1626225","volume":"16","author":"L Deng","year":"2025","unstructured":"Deng L, Lu S, Zeng J, Liu H. Global, regional, and National trends and burden of diabetes mellitus type 2 among youth from 1990 to 2021: an analysis from the global burden of disease study 2021. Front Endocrinol. 2025;16:1626225. https:\/\/doi.org\/10.3389\/fendo.2025.1626225.","journal-title":"Front Endocrinol"},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1186\/s12912-025-03814-2","volume":"24","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Comparing core competencies for diabetes specialist nurses across different countries: a scoping review. BMC Nurs. 2025;24:1358. https:\/\/doi.org\/10.1186\/s12912-025-03814-2.","journal-title":"BMC Nurs"},{"key":"2195_CR17","doi-asserted-by":"publisher","first-page":"876795","DOI":"10.3389\/fcvm.2022.876795","volume":"9","author":"LSF de Carvalho","year":"2022","unstructured":"de Carvalho LSF, et al. Glucose-Lowering and the risk of cardiovascular events with antidiabetic therapies: A systematic review and Additive-Effects network Meta-Analysis. Front Cardiovasc Med. 2022;9:876795. https:\/\/doi.org\/10.3389\/fcvm.2022.876795.","journal-title":"Front Cardiovasc Med"},{"key":"2195_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2337\/dc16-1943","volume":"40","author":"L Azoulay","year":"2017","unstructured":"Azoulay L, Suissa S. Sulfonylureas and the risks of cardiovascular events and death: A methodological Meta-Regression analysis of the observational studies. Diabetes Care. 2017;40:706\u201314. https:\/\/doi.org\/10.2337\/dc16-1943.","journal-title":"Diabetes Care"},{"key":"2195_CR19","doi-asserted-by":"publisher","first-page":"1436217","DOI":"10.3389\/fendo.2024.1436217","volume":"15","author":"F Wang","year":"2024","unstructured":"Wang F, et al. Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and cerebrovascular diseases: a meta-analysis of controlled clinical trials. Front Endocrinol (Lausanne). 2024;15:1436217. https:\/\/doi.org\/10.3389\/fendo.2024.1436217.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2195_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:234. https:\/\/doi.org\/10.1038\/s41392-024-01931-z.","journal-title":"Signal Transduct Target Ther"},{"key":"2195_CR21","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","volume":"149","author":"SM Patel","year":"2024","unstructured":"Patel SM, et al. Sodium-Glucose Cotransporter-2 inhibitors and major adverse cardiovascular outcomes: A SMART-C collaborative Meta-Analysis. Circulation. 2024;149:1789\u2013801. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.069568.","journal-title":"Circulation"},{"key":"2195_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12889-022-12885-8","volume":"22","author":"G Skoglund","year":"2022","unstructured":"Skoglund G, Nilsson BB, Olsen CF, Bergland A, Hilde G. Facilitators and barriers for lifestyle change in people with prediabetes: a meta-synthesis of qualitative studies. BMC Public Health. 2022;22:553. https:\/\/doi.org\/10.1186\/s12889-022-12885-8.","journal-title":"BMC Public Health"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/dci24-0001","volume":"47","author":"JB Green","year":"2024","unstructured":"Green JB, Crowley MJ, Thirunavukkarasu S, Maruthur NM, Oldenburg B. The final frontier in diabetes care: implementing research in Real-World practice. Diabetes Care. 2024;47:1299\u2013310. https:\/\/doi.org\/10.2337\/dci24-0001.","journal-title":"Diabetes Care"},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13098-023-01209-4","volume":"15","author":"C Dong","year":"2023","unstructured":"Dong C, et al. Effect of exercise interventions based on family management or self-management on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2023;15:232. https:\/\/doi.org\/10.1186\/s13098-023-01209-4.","journal-title":"Diabetol Metab Syndr"},{"key":"2195_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1753-0407.12847","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang W, Ning G. Metabolic management center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2019;11:11\u20133. https:\/\/doi.org\/10.1111\/1753-0407.12847.","journal-title":"J Diabetes"},{"key":"2195_CR26","doi-asserted-by":"publisher","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. J Biometrika. 1983;70:41\u201355. https:\/\/doi.org\/10.1093\/biomet\/70.1.41.","DOI":"10.1093\/biomet\/70.1.41"},{"key":"2195_CR27","doi-asserted-by":"publisher","first-page":"770025","DOI":"10.3389\/fcvm.2022.770025","volume":"9","author":"W-W Chang","year":"2022","unstructured":"Chang W-W, Fei S-Z, Pan N, Yao Y-S, Jin Y-L. Incident stroke and its influencing factors in patients with type 2 diabetes mellitus and\/or hypertension: A prospective cohort study. Front Cardiovasc Med. 2022;9:770025. https:\/\/doi.org\/10.3389\/fcvm.2022.770025.","journal-title":"Front Cardiovasc Med"},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"e0305954","DOI":"10.1371\/journal.pone.0305954","volume":"19","author":"M Zhao","year":"2024","unstructured":"Zhao M, Dong Y, Chen L, Shen H. Influencing factors of stroke in patients with type 2 diabetes: A systematic review and meta-analysis. PLoS ONE. 2024;19:e0305954. https:\/\/doi.org\/10.1371\/journal.pone.0305954.","journal-title":"PLoS ONE"},{"key":"2195_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12933-023-02038-5","volume":"22","author":"L Tan","year":"2023","unstructured":"Tan L, et al. Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study. Cardiovasc Diabetol. 2023;22:311. https:\/\/doi.org\/10.1186\/s12933-023-02038-5.","journal-title":"Cardiovasc Diabetol"},{"key":"2195_CR30","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). 2023;14:1149239. https:\/\/doi.org\/10.3389\/fendo.2023.1149239.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2195_CR31","doi-asserted-by":"publisher","unstructured":"Ormazabal V, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17. https:\/\/doi.org\/10.1186\/s12933-018-0762-4.","DOI":"10.1186\/s12933-018-0762-4"},{"key":"2195_CR32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","volume":"78","author":"G Jia","year":"2021","unstructured":"Jia G, Sowers JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78:1197\u2013205. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17981.","journal-title":"Hypertension"},{"key":"2195_CR33","doi-asserted-by":"publisher","unstructured":"Zhang J, et al. Endothelial metabolic control of insulin sensitivity through resident macrophages. Cell Metab. 2024;36. https:\/\/doi.org\/10.1016\/j.cmet.2024.08.008.","DOI":"10.1016\/j.cmet.2024.08.008"},{"key":"2195_CR34","doi-asserted-by":"publisher","first-page":"e0253492","DOI":"10.1371\/journal.pone.0253492","volume":"16","author":"J Yao","year":"2021","unstructured":"Yao J, et al. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials. PLoS ONE. 2021;16:e0253492. https:\/\/doi.org\/10.1371\/journal.pone.0253492.","journal-title":"PLoS ONE"},{"key":"2195_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","volume":"12","author":"CTTC Collaboration","year":"2024","unstructured":"Collaboration CTTC. Effects of Statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded Statin trials: an individual participant data meta-analysis. Lancet Diabetes Endocrinol. 2024;12:306\u201319. https:\/\/doi.org\/10.1016\/S2213-8587(24)00040-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2195_CR36","doi-asserted-by":"publisher","unstructured":"Jung TW, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice. Exp Mol Med. 2018;50. https:\/\/doi.org\/10.1038\/s12276-018-0147-5.","DOI":"10.1038\/s12276-018-0147-5"},{"key":"2195_CR37","doi-asserted-by":"publisher","first-page":"155817","DOI":"10.1016\/j.metabol.2024.155817","volume":"154","author":"J-X Chen","year":"2024","unstructured":"Chen J-X, et al. Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis. Metabolism. 2024;154:155817. https:\/\/doi.org\/10.1016\/j.metabol.2024.155817.","journal-title":"Metabolism"},{"key":"2195_CR38","doi-asserted-by":"publisher","unstructured":"DeFronzo RA, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1. https:\/\/doi.org\/10.1038\/nrdp.2015.19.","DOI":"10.1038\/nrdp.2015.19"},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","volume":"61","author":"S Verma","year":"2018","unstructured":"Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia. 2018;61:2108\u201317. https:\/\/doi.org\/10.1007\/s00125-018-4670-7.","journal-title":"Diabetologia"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02195-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:44:49Z","timestamp":1774431889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02195-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02195-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of this work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was conducted in accordance with the principles of the Declaration of Helsinki. Owing to the retrospective nature of the study, this research was approved by the Ethics Committee of Yan\u2019an University Affiliated Hospital (Ethics Approval No.: IIT-R-20250169) and the requirement for informed consent was waived. All patient data were anonymized to maintain confidentiality throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}